Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer.
about
Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Use of a genome-wide haploid g ...... le study in pancreatic cancer.
@en
Use of a genome-wide haploid g ...... le study in pancreatic cancer.
@nl
type
label
Use of a genome-wide haploid g ...... le study in pancreatic cancer.
@en
Use of a genome-wide haploid g ...... le study in pancreatic cancer.
@nl
prefLabel
Use of a genome-wide haploid g ...... le study in pancreatic cancer.
@en
Use of a genome-wide haploid g ...... le study in pancreatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
Use of a genome-wide haploid g ...... ple study in pancreatic cancer
@en
P2093
Ciaran B Woodman
Claire James
Daniel H Palmer
David Huen
Jennifer Anderton
Naheema Gordon
Sarah M Leonard
P2860
P304
63635-63645
P356
10.18632/ONCOTARGET.18879
P407
P50
P577
2017-06-29T00:00:00Z